Geode Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $45.1K | Sell |
|
|||||
|
2024
Q3 | $440K | Sell |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $1.18M | Buy |
|
|||||
|
2023
Q4 | $1.26M | Buy |
|
|||||
|
2023
Q3 | $545K | Buy |
|
|||||
|
2023
Q2 | $409K | Buy |
|
|||||
|
2023
Q1 | $222K | Buy |
|
|||||
|
2022
Q4 | $253K | Buy |
|
|||||
|
2022
Q3 | $453K | Buy |
|
|||||
|
2022
Q2 | $465K | Sell |
|
|||||
|
2022
Q1 | $1.17M | Buy |
|
|||||
|
2021
Q4 | $3.11M | Buy |
|
|||||
|
2021
Q3 | $3.83M | Sell |
|
|||||
|
2021
Q2 | $5.27M | Buy |
|
|||||
|
2021
Q1 | $6.23M | Buy |
|
|||||
|
2020
Q4 | $6.4M | Buy |
|
|||||
|
2020
Q3 | $5.13M | Buy |
|
|||||
|
2020
Q2 | $6.01M | Buy |
|
|||||
|
2020
Q1 | $2.95M | Buy |
|
|||||
|
2019
Q4 | $3.29M | Buy |
|
|||||
|
2019
Q3 | $4.68M | Buy |
|
|||||
|
2019
Q2 | $4.13M | Buy |
|
|||||
|
2019
Q1 | $2.65M | Buy |
|
|||||
|
2018
Q4 | $1.39M | Buy |
|
|||||
|
2018
Q3 | $2.7M | Buy |
|
|||||
|
2018
Q2 | $2.19M | Buy |
|
|||||
|
2018
Q1 | $2.12M | Buy |
|
|||||
|
2017
Q4 | $931K | Buy |
|
|||||
|
2017
Q3 | $1.4M | Buy |
|
|||||
|
2017
Q2 | $1.35M | Buy |
|
|||||
|
2017
Q1 | $638K | Buy |
|
|||||
|
2016
Q4 | $435K | Buy |
|
|||||
|
2016
Q3 | $481K | Buy |
|